β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease

CONTEXT β-Blockers remain the standard of care after a myocardial infarction (MI). However, the benefit of β-blocker use in patients with coronary artery disease (CAD) but no history of MI, those with a remote history of MI, and those with only risk factors for CAD is unclear. OBJECTIVE To assess th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA : the journal of the American Medical Association 2012-10, Vol.308 (13), p.1340-1349
Hauptverfasser:	Bangalore, Sripal, Steg, Gabriel, Deedwania, Prakash, Crowley, Kevin, Eagle, Kim A, Goto, Shinya, Ohman, E. Magnus, Cannon, Christopher P, Smith, Sidney C, Zeymer, Uwe, Hoffman, Elaine B, Messerli, Franz H, Bhatt, Deepak L
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - therapeutic use Aged Biological and medical sciences Cardiology. Vascular system Cardiovascular Diseases - mortality Cardiovascular Diseases - prevention & control Coronary Artery Disease - drug therapy Coronary Artery Disease - mortality Coronary heart disease Female General aspects Heart Hospitalization - statistics & numerical data Humans Incidence Longitudinal Studies Male Medical sciences Middle Aged Myocardial Infarction - drug therapy Myocardial Revascularization - statistics & numerical data Propensity Score Risk Factors Stroke - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!